Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma

Author： Bramwell Vivien  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.14, Iss.4, 2007-04, pp. : 1254-1256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant chemotherapy of soft tissue sarcoma—current status

By Judson Ian  

Sarcoma, Vol. 4, Iss. 4, 2000-12 ,pp. : 149-150

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

By                

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1707-1714

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy of Soft Tissue Sarcoma

By Wall Najme   Wall Najme  

Acta Oncologica, Vol. 42, Iss. 1, 2003-01 ,pp. : 55-61

Informa Healthcare

Access to resources Recommend Favorite

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

By Bertucci François  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy

By Viens P.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 205-212

Springer Publishing Company

Access to resources Recommend Favorite